ROCHESTER, N.Y.--Bausch & Lomb’s (NYSE: BOL) PureVision silicone hydrogel contact lens--withdrawn from the U.S. market following a 2002 court ruling in a patent dispute between B&L and CIBA Vision, the eyecare unit of Novartis (NYSE: NVS)--is going back on sale in the U.S. Following its loss in the court case, B&L transferred manufacturing and shipping of its PureVision CL to its facility in Waterford, Ireland and continued to sell the lens in markets outside the U.S.
Bookmarks